Healthcare provider profile · identity verified

Cara Reising, ANP-BC

Nurse Practitioner · EVANSVILLE, IN · NPI 1780919670

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	187	52
Atorvastatin Calcium	Atorvastatin Calcium	164	47
Amlodipine Besylate	Amlodipine Besylate	162	43
Hydrochlorothiazide	Hydrochlorothiazide	156	45
Pantoprazole Sodium	Pantoprazole Sodium	133	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	19
Prednisone	Prednisone	130	85
Metformin Hcl	Metformin Hcl	118	35
Lorazepam	Lorazepam	114	24
Rosuvastatin Calcium	Rosuvastatin Calcium	114	33
Meloxicam	Meloxicam	113	34
Lisinopril	Lisinopril	109	34
Methylprednisolone	Methylprednisolone	103	88
Simvastatin	Simvastatin	100	30
Zolpidem Tartrate	Zolpidem Tartrate	99	16
Omeprazole	Omeprazole	97	31
Alprazolam	Alprazolam	96	15
Citalopram Hbr	Citalopram Hydrobromide	96	32
Albuterol Sulfate Hfa	Albuterol Sulfate	95	21
Montelukast Sodium	Montelukast Sodium	93	32
Gabapentin	Gabapentin	91	25
Duloxetine Hcl	Duloxetine Hcl	78	18
Clonazepam	Clonazepam	74	12
Sertraline Hcl	Sertraline Hcl	72	16
Mounjaro	Tirzepatide	71	suppressed
Alendronate Sodium	Alendronate Sodium	65	14
Escitalopram Oxalate	Escitalopram Oxalate	64	21
Doxycycline Hyclate	Doxycycline Hyclate	63	41
Pregabalin	Pregabalin	61	suppressed
Cephalexin	Cephalexin	60	48
Losartan Potassium	Losartan Potassium	60	18
Furosemide	Furosemide	59	19
Metoprolol Succinate	Metoprolol Succinate	59	19
Bupropion Xl	Bupropion Hcl	56	19
Azithromycin	Azithromycin	54	51
Glipizide	Glipizide	54	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	20
Trazodone Hcl	Trazodone Hcl	50	16
Promethazine Hcl	Promethazine Hcl	49	suppressed
Clonidine Hcl	Clonidine Hcl	47	suppressed
Synthroid	Levothyroxine Sodium	47	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	suppressed
Spironolactone	Spironolactone	42	15
Diazepam	Diazepam	41	11
Tramadol Hcl	Tramadol Hcl	41	11
Amoxicillin	Amoxicillin	39	36
Ezetimibe	Ezetimibe	39	13
Metoprolol Tartrate	Metoprolol Tartrate	39	12
Ondansetron Hcl	Ondansetron Hcl	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Eliquis	Apixaban	36	suppressed
Fluconazole	Fluconazole	36	25
Carvedilol	Carvedilol	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	29
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Atenolol	Atenolol	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	23
Tamsulosin Hcl	Tamsulosin Hcl	31	12
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Potassium Chloride	Potassium Chloride	28	suppressed
Temazepam	Temazepam	28	suppressed
Ozempic	Semaglutide	27	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	26	suppressed
Celecoxib	Celecoxib	26	suppressed
Allopurinol	Allopurinol	25	suppressed
Cefdinir	Cefdinir	25	19
Estradiol	Estradiol	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Carbamazepine	Carbamazepine	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Levofloxacin	Levofloxacin	19	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Scopolamine	Scopolamine	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Buspirone Hcl	Buspirone Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Naproxen	Naproxen	16	suppressed
Armodafinil	Armodafinil	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Famotidine	Famotidine	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Bicalutamide	Bicalutamide	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	11
Methocarbamol	Methocarbamol	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Perphenazine	Perphenazine	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Invokana	Canagliflozin	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Baclofen	Baclofen	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Ramipril	Ramipril	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error